Molbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through OFS. Its patented ‘Truenat’ PCR platform enables rapid decentralized testing. FY25 revenue stood at Rs 1,020 crore, PAT Rs 138.5 crore. Promoters include Sriram family and Exxora Trading.
Warning Signal? FIIs cut stake in 11 smallcap stocks in the last 3 quarters; prices crash up to 70%
Reliance Power’s shares declined as the Enforcement Directorate filed a chargesheet in a fake bank guarantee case, weighing on investor sentiment and drawing renewed attention